Literature DB >> 32432785

Assumptions for disparities in case-fatality rates of coronavirus disease (COVID-19) across the globe.

K Undela1, S K Gudi.   

Abstract

In a short span, Coronavirus disease (COVID-19) has become the world pandemic by rapidly spreading almost to all the countries around the globe, irrespective of the continent, population size, economic status and healthcare system. Despite the number of cases increasing exponentially in most of the countries, there exist certain disparities in terms of case-fatality rates. As of April 24, 2020, the case-fatality rate of COVID-19 is about 7.0%, with 193,671 deaths and 2,761,121 confirmed cases around the world. Although the United States of America (USA), Spain, Italy, France, and Germany are the top-most affected counties in terms of confirmed cases; France, Italy and Spain are leading the list in terms of case-fatality rates. Therefore, through this mini-review, authors sought to brief on possible assumptions (five D's) that might contribute to the varying case-fatality rates among different countries across the globe.

Entities:  

Mesh:

Year:  2020        PMID: 32432785     DOI: 10.26355/eurrev_202005_21215

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

Review 1.  COVID-19 Case Fatality Rate and Factors Contributing to Mortality in Ethiopia: A Systematic Review of Current Evidence.

Authors:  Derara Girma; Hiwot Dejene; Leta Adugna; Mengistu Tesema; Mukemil Awol
Journal:  Infect Drug Resist       Date:  2022-07-04       Impact factor: 4.177

Review 2.  COVID-19: breaking down a global health crisis.

Authors:  Saad I Mallah; Omar K Ghorab; Sabrina Al-Salmi; Omar S Abdellatif; Tharmegan Tharmaratnam; Mina Amin Iskandar; Jessica Atef Nassef Sefen; Pardeep Sidhu; Bassam Atallah; Rania El-Lababidi; Manaf Al-Qahtani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-05-18       Impact factor: 3.944

3.  Knowledge and beliefs towards universal safety precautions during the coronavirus disease (COVID-19) pandemic among the Indian public: a web-based cross-sectional survey.

Authors:  Sai Krishna Gudi; Manik Chhabra; Krishna Undela; Rajesh Venkataraman; Uday Venkat Mateti; Komal Krishna Tiwari; Sanath Nyamagoud
Journal:  Drugs Ther Perspect       Date:  2020-07-04

Review 4.  SARS-CoV-2: characteristics and current advances in research.

Authors:  Yicheng Yang; Zhiqiang Xiao; Kaiyan Ye; Xiaoen He; Bo Sun; Zhiran Qin; Jianghai Yu; Jinxiu Yao; Qinghua Wu; Zhang Bao; Wei Zhao
Journal:  Virol J       Date:  2020-07-29       Impact factor: 4.099

5.  Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area.

Authors:  Giuliana Amaddeo; Raffaele Brustia; Manon Allaire; Marie Lequoy; Clémence Hollande; Hélène Regnault; Lorraine Blaise; Nathalie Ganne-Carrié; Olivier Séror; Edouard Larrey; Chetana Lim; Olivier Scatton; Sanaa El Mouhadi; Violaine Ozenne; François Paye; Pierre Balladur; Anthony Dohan; Pierre-Philippe Massault; Stanislas Pol; Marco Dioguardi Burgio; Valérie Vilgrain; Ailton Sepulveda; Francois Cauchy; Alain Luciani; Daniele Sommacale; Vincent Leroy; Francoise Roudot-Thoraval; Mohamed Bouattour; Jean-Charles Nault
Journal:  JHEP Rep       Date:  2020-12-22

6.  Visualizing and assessing US county-level COVID19 vulnerability.

Authors:  Gina Cahill; Carleigh Kutac; Nicholas L Rider
Journal:  Am J Infect Control       Date:  2020-12-19       Impact factor: 2.918

Review 7.  Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects.

Authors:  Shilia Jacob Kurian; Mazhuvancherry Kesavan Unnikrishnan; Sonal Sekhar Miraj; Debasis Bagchi; Mithu Banerjee; B Shrikar Reddy; Gabriel Sunil Rodrigues; Mohan K Manu; Kavitha Saravu; Chiranjay Mukhopadhyay; Mahadev Rao
Journal:  Arch Med Res       Date:  2021-03-19       Impact factor: 8.323

8.  SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?

Authors:  Sreedhar Chinnaswamy
Journal:  Am J Hum Biol       Date:  2020-09-23       Impact factor: 2.947

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.